| http://www.w3.org/ns/prov#value | - In at least some embodiments, the CBI CC-1065 analogs can be conjugated to targeting agents, such as an antibody, receptor, peptide, pectin, saccharide, nucleic acid or a combination thereof, for use in pharmaceutical compositions that selectively deliver the cytotoxic CBI CC-1065 analogs to desired target cells, such as carcinoma cells.
|
